AMG National Trust Bank Grows Position in Cigna Group $CI

AMG National Trust Bank boosted its stake in shares of Cigna Group (NYSE:CI) by 2.4% during the 2nd quarter, Holdings Channel.com reports. The firm owned 4,240 shares of the health services provider’s stock after buying an additional 101 shares during the quarter. AMG National Trust Bank’s holdings in Cigna Group were worth $1,402,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. IFG Advisory LLC lifted its position in Cigna Group by 6.5% during the second quarter. IFG Advisory LLC now owns 7,659 shares of the health services provider’s stock valued at $2,532,000 after purchasing an additional 470 shares in the last quarter. Simon Quick Advisors LLC lifted its position in Cigna Group by 41.1% during the second quarter. Simon Quick Advisors LLC now owns 4,443 shares of the health services provider’s stock valued at $1,469,000 after purchasing an additional 1,294 shares in the last quarter. AdvisorShares Investments LLC purchased a new position in Cigna Group during the second quarter valued at $473,000. Strs Ohio lifted its position in Cigna Group by 18.5% during the second quarter. Strs Ohio now owns 71,337 shares of the health services provider’s stock valued at $23,583,000 after purchasing an additional 11,144 shares in the last quarter. Finally, Heritage Investors Management Corp lifted its position in Cigna Group by 0.8% during the second quarter. Heritage Investors Management Corp now owns 12,691 shares of the health services provider’s stock valued at $4,195,000 after purchasing an additional 95 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Down 1.0%

Shares of CI stock opened at $244.67 on Friday. Cigna Group has a 12-month low of $240.67 and a 12-month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock’s 50-day moving average price is $297.19 and its 200-day moving average price is $306.12. The stock has a market capitalization of $65.31 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the previous year, the firm posted $7.51 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is 32.97%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CI shares. Truist Financial set a $375.00 target price on Cigna Group in a research report on Tuesday, September 2nd. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Wolfe Research lowered their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. The Goldman Sachs Group assumed coverage on Cigna Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $370.00 price objective on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $363.33.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.